Grant: Project Grant
Research Institute of the McGill University Health Centre
$100,000.00
The Canadian Multicentre Osteoporosis Study
EF 2016-17
Résumé
Osteoporosis is a disease characterized by a reduction in the quantity and/or quality of bone leading to decreased bone strength and an increased predisposition to fracture. It is the most common bone disease in humans, represents a major public health problem in an aging society, and produces a highly significant financial burden on the health care system. There are both genetic and environmental influences that contribute to its development, although most have yet to be defined. The Canadian Multicentre Osteoporosis Study (CaMos) is a trans-Canadian study which, in 1995, recruited 9423, mainly Caucasian, women and men over age 25 from the region surrounding 9 Canadian cities from Vancouver, BC to St John`s, NFLD. CaMos collected medical, biochemical (including genetic) and radiologic information at intervals over the years in these randomly selected participants which is unprecedented in Canada and unique worldwide. However in light of increasing ethnocultural diversity in Canada, visible minorities now represent almost 20% of the Canadian population Our current objectives are to examine the demographics of osteoporosis in a new cohort of participants of Chinese origin (one of the largest Canadian non-Caucasian groups), to compare these with our existing group of CaMos participants, and to identify genetic and environmental determinants of osteoporosis in these populations. These studies should improve our capacity to better identify those at risk for osteoporosis and osteoporotic fractures, and lead to improved strategies for modifying lifestyles and to potential new drugs for treatment. The consequences should therefore be improved prevention of fractures in the elderly, which is a major cause of illness and death, and lead to a reduction in the health care burden of this disease.
Programme
Project Grant
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
366540
Name
Goltzman David
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Project Grant Competition
Projecttitle
The Canadian Multicentre Osteoporosis Study
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Biomarkers; Epidemiology; Genetics; Imaging; Nutrition; Osteoporosis; Risk Factors
Abstract
Osteoporosis is a disease characterized by a reduction in the quantity and/or quality of bone leading to decreased bone strength and an increased predisposition to fracture. It is the most common bone disease in humans, represents a major public health problem in an aging society, and produces a highly significant financial burden on the health care system. There are both genetic and environmental influences that contribute to its development, although most have yet to be defined. The Canadian Multicentre Osteoporosis Study (CaMos) is a trans-Canadian study which, in 1995, recruited 9423, mainly Caucasian, women and men over age 25 from the region surrounding 9 Canadian cities from Vancouver, BC to St John`s, NFLD. CaMos collected medical, biochemical (including genetic) and radiologic information at intervals over the years in these randomly selected participants which is unprecedented in Canada and unique worldwide. However in light of increasing ethnocultural diversity in Canada, visible minorities now represent almost 20% of the Canadian population Our current objectives are to examine the demographics of osteoporosis in a new cohort of participants of Chinese origin (one of the largest Canadian non-Caucasian groups), to compare these with our existing group of CaMos participants, and to identify genetic and environmental determinants of osteoporosis in these populations. These studies should improve our capacity to better identify those at risk for osteoporosis and osteoporotic fractures, and lead to improved strategies for modifying lifestyles and to potential new drugs for treatment. The consequences should therefore be improved prevention of fractures in the elderly, which is a major cause of illness and death, and lead to a reduction in the health care burden of this disease.
Competitiondate
201611
Approvedterm2
1 yr 0 mth
Pinamesdelim
Goltzman, David; Kreiger, Nancy
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~